How to Test MDMA on your. own
Research

How to Test MDMA

While you’ve never fashioned as a chemist, knowing how to test MDMA is important since it is very difficult for an individual user to be 100% certain what’s in any given dose due to the fact it currently illegal and therefore not regulated.   With the resurgence of music festivals in the summer of  21 as […]

No Comments Read More
Ketamine as a Rapid Onset Antidepressant
Research

Ketamine as a Rapid Onset Antidepressant

The discovery of the ketamine as a rapid onset antidepressant and further exploration into processes involved could significantly impact treatment for patients as well as public health worldwide. Ketamine and The Next Generation of Antidepressants with a Rapid Onset of Action The article below is part of Frshmind’s “Psychedelic Science Snapshot Series” where Frshminds reviews […]

No Comments Read More
Psilocybin and Smoking Cessation
Research

Psilocybin and Smoking Cessation

Most smokers can attest to always looking to kick the habit, and now research is exploring the linkage between psilocybin and smoking cessation. Johns Hopkins researchers report 15 study participants taking psilocybin, the active hallucinogenic agent in “magic mushrooms.” achieved an 80 percent abstinence rate over six months, compared to an approximate 35 percent success […]

No Comments Read More
Ketamine for Unipolar and Bipolar Depression
Research

Ketamine for Unipolar and Bipolar Depression

Early clinical trials demonstrate that using intravenous and intranasal ketamine for unipolar and bipolar depression offer the possibility for safe and rapid relief of symptoms with high response rates (up to 88%) and pronounced antisuicidal effects. Administration of Ketamine for Unipolar and Bipolar Depression The article below is part of Frshmind’s “Psychedelic Science Snapshot Series” […]

No Comments Read More
MDMA Assisted Psychotherapy for PTSD
Research

MDMA Assisted Psychotherapy for PTSD

First synthesized in 1912, it was not until the early 1970s that MDMA Assisted Psychotherapy for PTSD was investigated. While reports described the potential for MDMA to facilitate communication and connection between therapists and patients, the 80’s saw the recreational use of MDMA became popular, leading to its classification as a Schedule 1 controlled substance […]

No Comments Read More
Drug and Harm in the United Kingdom
Research

Researching the Association between Drug and Harm in the United Kingdom

Drug harms in the UK: a multi criteria decision analysis The article below is part of Frshmind’s “Psychedelic Science Snapshot Series” where Frshminds reviews the latest in psychedelic research. Original authors:David J. Nutt, Leslie A. King, and Lawrence D. Phillips, on behalf of the Independent Scientific Committee on DrugsSummarized by: Emily Fewster Introduction Drugs such […]

No Comments Read More
Ketamine Assisted Psychotherapy
Research

Ketamine Assisted Psychotherapy (KAP): Demographics, Data and Outcomes

By now you’ve probably heard a bit about the potential benefits of ketamine assisted psychotherapy. Read on as Frshminds’ Emily Frewster takes you behind the curtain to explore a bit of the research into ketamine assisted psychotherapy. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy […]

No Comments Read More
The history of psychedelic-treatments-for mental health disorders
Research

The History of Psychedelic Treatments for Mental Health Disorders

Spoiler Alert…it involves toads! You would be mistaken if you think the history of psychedelic treatments for mental health disorders started in the 1960’s.  While the first psychedelic compound was first derived  in 1938 when Albert Hofmann, a Swiss researcher, synthesized LSD while working with a different chemical called ergot, ancient cultures have be using […]

No Comments Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.